Bradley L Newswander, DPM | |
5656 S Power Rd Ste 124, Gilbert, AZ 85295-8489 | |
(480) 840-3457 | |
(480) 840-3458 |
Full Name | Bradley L Newswander |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 24 Years |
Location | 5656 S Power Rd Ste 124, Gilbert, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740254036 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 575 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Banner Ironwood Medical Center | Queen creek, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bradley L Newswander Dpm Plc | 4082690771 | 3 |
News Archive
The endothelial cells that line blood vessels are packed tightly to keep blood inside and flowing, but scientists at Rice University and their colleagues have discovered it may be possible to selectively open gaps in those barriers just enough to let large molecules through - and then close them again.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
The National Coalition for Cancer Survivorship (NCCS) has accepted an invitation to join the Commission on Cancer (CoC), a multidisciplinary organization administered by the American College of Surgeons dedicated to reducing the morbidity and mortality of cancer through education, standards setting, and the monitoring of quality of care.
Left a sponge inside the patient? Transfused the wrong blood type? Don't look for the federal government to pay for fixing the mistake. Medicaid will no longer pay hospitals or doctors for certain preventable illnesses and injuries, such as operating on the wrong body part, the Health and Human Services Department said Wednesday.
Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center.
› Verified 4 days ago
Provider Name | Bradley L Newswander Dpm Plc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1740488246 PECOS PAC ID: 4082690771 Enrollment ID: O20040624001199 |
News Archive
The endothelial cells that line blood vessels are packed tightly to keep blood inside and flowing, but scientists at Rice University and their colleagues have discovered it may be possible to selectively open gaps in those barriers just enough to let large molecules through - and then close them again.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
The National Coalition for Cancer Survivorship (NCCS) has accepted an invitation to join the Commission on Cancer (CoC), a multidisciplinary organization administered by the American College of Surgeons dedicated to reducing the morbidity and mortality of cancer through education, standards setting, and the monitoring of quality of care.
Left a sponge inside the patient? Transfused the wrong blood type? Don't look for the federal government to pay for fixing the mistake. Medicaid will no longer pay hospitals or doctors for certain preventable illnesses and injuries, such as operating on the wrong body part, the Health and Human Services Department said Wednesday.
Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Bradley L Newswander, DPM 5656 S Power Rd Ste 124, Gilbert, AZ 85295-8489 Ph: (480) 840-3457 | Bradley L Newswander, DPM 5656 S Power Rd Ste 124, Gilbert, AZ 85295-8489 Ph: (480) 840-3457 |
News Archive
The endothelial cells that line blood vessels are packed tightly to keep blood inside and flowing, but scientists at Rice University and their colleagues have discovered it may be possible to selectively open gaps in those barriers just enough to let large molecules through - and then close them again.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
The National Coalition for Cancer Survivorship (NCCS) has accepted an invitation to join the Commission on Cancer (CoC), a multidisciplinary organization administered by the American College of Surgeons dedicated to reducing the morbidity and mortality of cancer through education, standards setting, and the monitoring of quality of care.
Left a sponge inside the patient? Transfused the wrong blood type? Don't look for the federal government to pay for fixing the mistake. Medicaid will no longer pay hospitals or doctors for certain preventable illnesses and injuries, such as operating on the wrong body part, the Health and Human Services Department said Wednesday.
Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center.
› Verified 4 days ago
Dr. Andrew Goodeill, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4915 E Baseline Rd, Ste 121, Gilbert, AZ 85234 Phone: 480-812-3668 Fax: 480-782-1290 | |
Mahsa Agha Jafari, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4915 E Baseline Rd Ste 121, Gilbert, AZ 85234 Phone: 480-812-3668 Fax: 480-782-1290 | |
Sun Valley Foot And Ankle Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 3336 E Chandler Heights Rd Ste 121, Gilbert, AZ 85298 Phone: 480-245-7027 | |
Dr. Robert Christopher Andersen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3336 E Chandler Heights Rd Ste 121, Gilbert, AZ 85298 Phone: 480-245-7027 | |
James E Schmidt, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2353 E Baseline Rd Ste 105, Gilbert, AZ 85234 Phone: 602-491-0701 | |
Spectrum Falls Foot & Ankle Specialists, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2730 S Val Vista Dr, Suite 158, Gilbert, AZ 85296 Phone: 480-889-7055 Fax: 480-889-7054 | |
Christopher Van Damme, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4915 E Baseline Rd Ste 121, Gilbert, AZ 85234 Phone: 480-812-6882 |